# Novanta Inc. – Consensus ‘buy’ rating and 13.2% Upside Potential

- Link: https://www.directorstalkinterviews.com/novanta-inc.consensus-buy-rating-and-13.2-upside-potential/4121130296
- Published: 2023-10-20T13:51:42+01:00
- Author: Charlotte Edwards

**Novanta Inc.** with ticker code (NOVT) now have 2 analysts in total covering the
stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges
between 169 and 162 calculating the mean target price we have $165.50. Given that
the stocks previous close was at $146.24 this now indicates there is a potential
upside of 13.2%. The 50 day moving average now sits at $151.08 while the 200 day
moving average is $159.10. The market capitalization for the company is 4.96B. The
stock price for the company is currently 138.39 USD

 The potential market cap would be $5,608,158,060 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 64.37, revenue per share of 24.87
and a 6.23% return on assets.

Novanta Inc. is a global supplier of core technology solutions to medical and advanced
industrial original equipment manufacturers. Its segments include Photonics, Vision,
and Precision Motion. The Photonics segment designs, manufactures and markets photonics-
based solutions, including laser scanning, laser beam delivery, carbon dioxide (
CO2) laser, solid state laser, ultrafast laser, and optical light engine products
to customers worldwide. The Vision segment designs, manufactures and markets a range
of medical grade technologies, including medical insufflators, pumps and related
disposables; visualization solutions; wireless technologies, video recorder and 
video integration technologies. The Precision Motion segment designs, manufactures
and markets optical and inductive encoders, precision motors, servo drives and motion
control solutions, integrated stepper motors, intelligent robotic end-of-arm technology
solutions, air bearings, and air bearing spindles to customers worldwide.

Share on: